Isabel Morgado, PhD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Researchers
Isabel Morgado, PhD

Isabel Morgado, PhD

Researcher
Scientist I
Nurix Therapeutics, Inc.
1700 Owens Street, Suite 205
San Francisco, California, United States
Dr. Isabel Morgado is working as a Scientist I at Nurix Therapeutics. She received her Ph.D. in Molecular Biology from the University of Algarve in Portugal, where she studied the structure-to-function evaluation and amyloid formation by the protein transthyretin. Since then, her research interest has focused on protein misfolding and amyloid diseases. Dr. Isabel Morgado was a DFG fellow at the Max Planck Research Unit for Protein Folding, studying Aβ amyloid formation, and a Marie Curie fellow at the Center of Marine Sciences of Algarve and Boston University, investigating transthyretin and apolipoprotein A-I amyloidosis. 
 
Previously, Dr. Isabel Morgado worked as an Instructor at Stanford and Dr. Liao’s lab to uncover mechanisms of amyloid diseases, in particular transthyretin cardiac amyloidosis, using in vivo zebrafish models.
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close